These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24188277)

  • 21. Platelet-derived growth factor expression and stimulation in human meningiomas.
    Black PM; Carroll R; Glowacka D; Riley K; Dashner K
    J Neurosurg; 1994 Sep; 81(3):388-93. PubMed ID: 8057146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
    Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M
    Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas.
    Johnson MD; Shaw AK; O'Connell MJ; Sim FJ; Moses HL
    J Neurooncol; 2011 Jun; 103(2):277-85. PubMed ID: 20853018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway.
    Johnson MD; O'Connell MJ; Vito F; Pilcher W
    J Neuropathol Exp Neurol; 2009 Nov; 68(11):1177-83. PubMed ID: 19816200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways.
    Johnson MD; Okediji E; Woodard A
    J Neurooncol; 2004 Jan; 66(1-2):9-16. PubMed ID: 15015765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways.
    Mehdi Üremiş M; Üremiş N; Tosun E; Durhan M; Çiğremiş Y; Baysar A; Türköz Y
    Curr Cancer Drug Targets; 2022; 22(11):931-944. PubMed ID: 35786188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation.
    Zhang MX; Zhao X; Wang ZG; Zhao WM; Wang YS
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):981-8. PubMed ID: 20052595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells.
    Johnson MD; Woodard A; Kim P; Frexes-Steed M
    J Neurosurg; 2001 Feb; 94(2):293-300. PubMed ID: 11213968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas.
    Graillon T; Defilles C; Mohamed A; Lisbonis C; Germanetti AL; Chinot O; Figarella-Branger D; Roche PH; Adetchessi T; Fuentes S; Metellus P; Dufour H; Enjalbert A; Barlier A
    J Neurooncol; 2015 Aug; 124(1):33-43. PubMed ID: 26015296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
    Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
    Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
    Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
    Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
    Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
    Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway.
    Zhang L; Liang H; Xin Y
    Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.
    Ishdorj G; Johnston JB; Gibson SB
    BMC Cancer; 2011 Jun; 11():268. PubMed ID: 21702955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2.
    Park YS; Lee JH; Harwalkar JA; Bondar J; Safayhi H; Golubic M
    Adv Exp Med Biol; 2002; 507():387-93. PubMed ID: 12664615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].
    Liu C; Xie C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):870-5. PubMed ID: 27363263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
    Graillon T; Sanson M; Campello C; Idbaih A; Peyre M; Peyrière H; Basset N; Autran D; Roche C; Kalamarides M; Roche PH; Fuentes S; Tabouret E; Barrie M; Cohen A; Honoré S; Boucekine M; Baumstarck K; Figarella-Branger D; Barlier A; Dufour H; Chinot OL
    Clin Cancer Res; 2020 Feb; 26(3):552-557. PubMed ID: 31969329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma.
    Zhu H; Miao Y; Shen Y; Guo J; Xie W; Zhao S; Dong W; Zhang Y; Li C
    J Transl Med; 2019 Oct; 17(1):354. PubMed ID: 31665029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.